Stocks › NNVC

NANOVIRICIDES, INC.

NNVC·NYSE·United States United States·USD
$1.14
-0.03 (-2.56%)
Close · Nov 20, 2026 · Close Prices from Tiingo.com
NNVC
NANOVIRICIDES, INC. · NYSE
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
NNVCS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair

Congressional Trades

Recent trades of NNVC by members of U.S. Congress · 1 on record
All congressional trades →
PoliticianStockTypeFiledTraded
Kelly LoefflerKelly LoefflerSenate · R · GA NNVCNANOVIRICIDES, INC. · Stock Sale
$1,001 - $15,000
May 1, 2020 Apr 7, 2020 Filing ↗

Whale Activity

Position changes in NNVC reported for 2026-09-30 by 56 institutional filers
Increased: 9New: 10Held: 25Decreased: 5Closed: 7
  • Increased9
  • New10
  • Held25
  • Decreased5
  • Closed7
  • No prior filing0
FilerSharesValueChange
VANGUARD CAPITAL MANAGEMENT LLC919.3K$1.2Mheld
GEODE CAPITAL MANAGEMENT, LLC229.5K$298Kincreased
BlackRock, Inc.158.8K$206Kheld
Miller Financial Services LLC134.0K$174Kincreased
VANGUARD FIDUCIARY TRUST CO131.9K$172Kheld
SUSQUEHANNA INTERNATIONAL GROUP, LLP126.3K$164Kincreased
RENAISSANCE TECHNOLOGIES LLC98.3K$128Kdecreased
Creative Planning86.8K$113Kheld
UBS Group AG70.4K$92Kdecreased
NORTHERN TRUST CORP64.2K$83Kincreased
STATE STREET CORP54.2K$70Kheld
Empowered Funds, LLC35.4K$46Knew

Every 13F filer's complete reported book, every quarter since 2013-06-30. 13F itself excludes short positions, cash and most options.

Insider Trading

Net shares bought (+) or sold (−) on the open market by NNVC insiders, by quarter · Form 4

No open-market insider buys or sells in the last two years.

Recent Insider Transactions

92 transactions on record · newest first
All insider activity →
InsiderTypeSharesPriceValueDate
Diwan AnilPresident · Director Gift −94.5K $0.00 $0 Aug 8, 2022 Form 4 ↗
BONIUK MILTON10% owner Option exercise +5.5M — — May 21, 2018 Form 4 ↗
BONIUK MILTON10% owner Grant / award +120.7K — — Jul 11, 2017 Form 4 ↗
BONIUK MILTON10% owner Grant / award +149.5K — — May 4, 2017 Form 4 ↗
BONIUK MILTON10% owner Grant / award +153.6K — — Feb 21, 2017 Form 4 ↗
BONIUK MILTON10% owner Option exercise +1.7M — — Feb 21, 2017 Form 4 ↗
BONIUK MILTONDirector Other −605.5K $0.00 $0 Feb 1, 2017 Form 4 ↗
BONIUK MILTONDirector Grant / award +25.0K $1.50 $38K May 19, 2016 Form 4 ↗
BONIUK MILTONDirector Grant / award +25.0K $1.50 $38K May 12, 2016 Form 4 ↗
BONIUK MILTONDirector Grant / award +15.0K $1.68 $25K May 4, 2016 Form 4 ↗
BONIUK MILTONDirector Grant / award +2,900 $1.68 $5K Apr 29, 2016 Form 4 ↗
BONIUK MILTONDirector Grant / award +7,109 $1.68 $12K Apr 28, 2016 Form 4 ↗
BONIUK MILTONDirector Grant / award +25.0K $1.78 $45K Apr 27, 2016 Form 4 ↗
BONIUK MILTONDirector Grant / award +9,000 $1.70 $15K Feb 18, 2016 Form 4 ↗
BONIUK MILTONDirector Grant / award +141.8K $1.18 $167K Feb 12, 2016 Form 4 ↗
BONIUK MILTONDirector Grant / award +34.0K $1.18 $40K Feb 12, 2016 Form 4 ↗
BONIUK MILTONDirector Grant / award +34.0K $1.18 $40K Feb 12, 2016 Form 4 ↗
BONIUK MILTONDirector Grant / award +9,000 $1.36 $12K Feb 10, 2016 Form 4 ↗
BONIUK MILTONDirector Grant / award +9,000 $1.40 $13K Feb 8, 2016 Form 4 ↗
BONIUK MILTONDirector Purchase +25.0K $1.20 $30K Nov 11, 2015 Form 4 ↗

Fund Holders

Mutual funds and ETFs holding NNVC · SEC Form N-PORT
FundSharesValue% of fundAs of
VANGUARD TOTAL STOCK MARKET INDEX FUND
VANGUARD INDEX FUNDS
653.5K$902K0.00%Jun 30, 2026
VANGUARD EXTENDED MARKET INDEX FUND
VANGUARD INDEX FUNDS
245.3K$339K0.00%Jun 30, 2026
Fidelity Extended Market Index Fund
Fidelity Concord Street Trust
124.6K$156K0.00%Aug 31, 2026
Ultra-Small Company Market Fund
Bridgeway Funds, Inc.
36.0K$50K0.03%Jun 30, 2026
Fidelity Series Total Market Index Fund
Fidelity Concord Street Trust
35.3K$44K0.00%Aug 31, 2026
Fidelity Total Market Index Fund
Fidelity Concord Street Trust
23.7K$30K0.00%Aug 31, 2026
VANGUARD BALANCED INDEX FUND
VANGUARD VALLEY FORGE FUNDS
20.5K$28K0.00%Jun 30, 2026

Mutual funds and ETFs whose N-PORT filings list NNVC's shares (CUSIP 630087302), each fund at its latest report since Apr 21, 2026, largest positions first. Bonds, options and short positions are left out.

Activist & Passive Stakes

Schedule 13D / 13G beneficial-ownership filings

No 13D/13G beneficial-ownership filings on record.

Corporate Lobbying

Estimated quarterly lobbying spending reported under the LDA, filings naming NANOVIRICIDES, INC. as client

No lobbying filings found naming NANOVIRICIDES, INC. as the client.

Government Contracts

Federal awards to NANOVIRICIDES, INC. · USAspending

No federal contract awards found for NANOVIRICIDES, INC..

U.S. Patents

Recent USPTO applications naming NANOVIRICIDES, INC.

No USPTO patent applications found for NANOVIRICIDES, INC..

Annual Financials

From NNVC's 10-K filings · XBRL
Fiscal yearFY2026FY2025FY2024FY2023FY2022
Operating income-$8.3M-$9.6M-$8.5M-$8.9M-$8.1M
Net income-$8.2M-$9.5M-$8.3M-$8.6M-$8.1M
Diluted EPS-$0.41-$0.63-$0.70-$0.74-$0.70
Operating cash flow-$7.7M-$8.5M-$6.3M-$5.7M-$5.9M
Cash and equivalents$2.8M$1.6M$4.8M$8.1M$14.1M
Total assets$9.9M$8.8M$12.8M$16.9M$23.5M
Total liabilities$1.2M$1.3M$1.4M$2.0M$413K
Shareholders' equity$8.7M$7.5M$11.5M$14.9M$23.1M

As NANOVIRICIDES, INC. tagged them in its 10-K filings: totals for the year on the income and cash-flow lines, values at the year's end on the balance-sheet lines. Latest 10-K, filed Sep 28, 2026 ↗

Stock Splits

Every split and reverse split in the price history
  • 1-for-20Reverse splitSep 24, 2019

Split dates and ratios from the price history · Close Prices from Tiingo.com

Material Events (8-K)

Corporate events filed with the SEC
  • 8-K · Items 5.02, 9.01Officer / director changeSep 29, 2026
    EDGAR ↗
  • 8-K · Items 1.01, 8.01, 9.01Material agreement · Other eventsJul 30, 2026
    EDGAR ↗
  • 8-K · Items 1.01, 9.01Material agreementJul 17, 2026
    EDGAR ↗
  • 8-K · Items 7.01Reg FD disclosureMay 21, 2026
    EDGAR ↗
  • 8-K · Items 1.01, 8.01, 9.01Material agreement · Other eventsMay 20, 2026
    EDGAR ↗

About NANOVIRICIDES, INC.

From SEC EDGAR company records

Organization and Nature of Business NanoViricides, Inc. (the “Company”, “NanoViricides”, “we,” or “us”) was incorporated in Nevada on April 1, 2005, and redomiciled to Delaware effective May 30, 2023. Our corporate offices are located at 1 Controls Drive, Shelton, Connecticut 06484 and our telephone number is (203) 937-6137. Our Website is located at http://www.Nanoviricides.com. We do not incorporate by reference into this Annual Report the information on or accessible through our website, and you should not consider it part of this Annual Report. On September 25, 2013, the Company’s common stock began trading on the New York Stock Exchange American under the symbol, “NNVC”. We are a clinic…

Industry (SIC 2834)Pharmaceutical Preparations
SectorHealthcare
HeadquartersSHELTON, CT
IncorporatedDE